XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
3 Months Ended
Feb. 15, 2022
Jan. 17, 2022
Jan. 03, 2022
Mar. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Dec. 29, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock options issued       163,692      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term       3 years      
Common stock, shares issued       7,784,444 1,600,835 240,125,224 240,125,244
Common stock, shares outstanding       7,784,444 1,600,835 240,125,224 240,125,244
Common stock, shares authorized       200,000,000 850,000,000    
Preferred stock, shares authorized       25,000,000 150,000,000    
Net proceeds from sale of common stock $ 22,000,000            
Number of shares sold 6,572,808            
Exercise price       $ 5.03 $ 9.59    
Par value       $ 0.00001 $ 0.00001    
Preferred stock, shares issued       0      
Preferred stock, shares outstanding       0      
Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of shares issued during the period       5,811,138      
Number of shares sold 5,811,138            
Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant term 5 years            
Exercise price $ 5.00            
Board of Directors Chairman [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock, shares authorized         200,000,000    
Preferred stock, shares authorized         25,000,000    
Underwriters [Member] | Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Exercise price $ 5.1625            
Stock issued during period, shares, issued for services 290,557            
Warrants maturity date Feb. 10, 2027            
2021 Equity Incentive Plan [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock options issued     3,125        
Exercise price     $ 4.80        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term     5 years        
Number of shares issued during the period       3,367      
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, granted   3,367          
Number of shares issued during the period   3,367          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Two Directors [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, vested   1,684          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | January 17, 2022 [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, granted   1,684          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | January 17, 2023 [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, granted   1,683